NEURX DIAPHRAGM PACING SYSTEM 20-0035

MAUDE Adverse Event Report

MAUDE data represents reports of adverse events involving medical devices. This maude entry was filed from a 05,07 report with the FDA on 2012-09-07 for NEURX DIAPHRAGM PACING SYSTEM 20-0035 manufactured by Synapse Biomedical Inc..

Event Text Entries

[2882992] The pt is a young male who sustained severe chest injuries and had been on positive-pressure mechanical ventilation for over 200 days. A one-time irb approval for an off-label use was obtained to attempt to strengthen the pt's diaphragm and wean him off mechanical ventilation. The pt was using the device on a normal course since surgical implantation on (b)(6) 2012. In a routine check for cardiac rhythm capture during the surgery (per the instructions for use) premature ventricular contractions (pvcs) were detected with the device at maximum stimulation settings. The stimulation settings were adjusted down accordingly and the pvcs were no longer seen. Over the course of the next 20 days the device stimulation parameters were adjusted to resolve pain issues, deal with diaphragm fatigue, and improve hypoventilation at night. This did involve increasing the stimulation parameters although no pvcs or vtach were noted. On (b)(6) 2012, approx 40 minutes after the device was turned on for the night, the pt experienced ventricular tachycardia and ventricular fibrillation. Cpr was performed, cardioversion was done 3 times, and 1 mg of epinephrine was administered to restore normal rhythm. The episode lasted 4 minutes. The device was in use at the time of the incident. The facility considered the event "serious" and "possibly related". It cannot be definitively determined whether the device contributed to the incident or not. The pt completely recovered and has been using the device since the incident at lower stimulation setting without recurrence.
Patient Sequence No: 1, Text Type: D, B5


[10103561] Because this was an off-label use of the device and a decision was made to increase the stimulation parameters although there was a previously identified susceptibility to cardiac rhythm interference, we do not believe any further action is indicated in response to this incident. The institution and medical professionals involved followed appropriate procedures for an off-label use, including appropriate pt monitoring, in an attempt to help the pt with previously unsuccessful ventilatory weaning. We understand that the pt has weaned from mechanical ventilation and is healthy (previous injuries not withstanding). This appears to be a reasonable practice of medicine with risks appropriately managed and there is no indication of a device malfunction.
Patient Sequence No: 1, Text Type: N, H10


MAUDE Entry Details

Report Number3005868392-2012-00001
MDR Report Key2739305
Report Source05,07
Date Received2012-09-07
Date of Report2012-09-06
Date of Event2012-07-29
Date Mfgr Received2012-08-08
Device Manufacturer Date2012-04-17
Date Added to Maude2012-09-12
Event Key0
Report Source CodeManufacturer report
Manufacturer LinkY
Number of Patients in Event0
Adverse Event Flag3
Product Problem Flag3
Reprocessed and Reused Flag0
Reporter OccupationOTHER HEALTH CARE PROFESSIONAL
Health Professional0
Initial Report to FDA3
Report to FDA0
Event Location0
Manufacturer Street300 ARTINO STREET
Manufacturer CityOBERLIN OH 44074
Manufacturer CountryUS
Manufacturer Postal44074
Manufacturer Phone4407742488
Single Use0
Previous Use Code3
Event Type3
Type of Report3

Device Details

Brand NameNEURX DIAPHRAGM PACING SYSTEM
Generic NameOIR DIAPHRAGMATIC/PHRENIC NERVE STIMULATOR
Product CodeHCC
Date Received2012-09-07
Model Number20-0035
Lot Number20-0035-041712-10-8
Device Expiration Date2013-04-30
OperatorHEALTH PROFESSIONAL
Device AgeDA
Device Eval'ed by MfgrR
Device Sequence No1
Device Event Key0
ManufacturerSYNAPSE BIOMEDICAL INC.
Manufacturer Address300 ARTINO STREET OBERLIN OH 44074 US 44074


Patients

Patient NumberTreatmentOutcomeDate
101. Life Threatening; 2. Required No Informationntervention 2012-09-07

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.